Titus B. Ball sold $47k of ONC
Principal Accounting Officer at BeiGene, Ltd.. 132 shares at an average of $355.86, traded Sep 1, 2026, filed Sep 3, 2026.
Score components
- +15RoleOfficer
- +6Trade size$47k at market
- +20Share of holdings soldSold 100% of holdings
- +8Cluster2 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001675628-26-000003, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 1, 2026 | SOpen-market sale American Depositary Shares | -132 | $355.86 | $47k | 0 | 38 d ago |
Related signals
Other insiders at BeiGene, Ltd. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 39Weak | BeiGene, Ltd. | Chan Henry Lee SVP, General Counsel | $418k 1,115 shares | -100% | |
| 33Weak | BeiGene, Ltd. | Xiaodong Wang director, other | $11M 31,028 shares | -100% | |
| 33Weak | BeiGene, Ltd. | Xiaodong Wang director, other | $13M 38,287 shares | -527% | |
| 40Moderate | BeiGene, Ltd. | Xiaodong Wang director, other | $11M 41,760 shares | -100% | |
| 70Notable | BeiGene, Ltd. | John Oyler Chief Executive Officer | $10M 41,210 shares | -100% | |
| 45Moderate | BeiGene, Ltd. | Xiaobin Wu President, COO & GM China | $14M 51,921 shares | -100% | |
| 70Notable | BeiGene, Ltd. | John Oyler Chief Executive Officer | $10M 40,109 shares | -100% | |
| 70Notable | BeiGene, Ltd. | John Oyler Chief Executive Officer | $15M 58,590 shares | -100% | |
| 55Moderate | BeiGene, Ltd. | Xiaodong Wang director, other | $2.1M 8,146 shares | -100% | |
| 70Notable | BeiGene, Ltd. | John Oyler Chief Executive Officer | $25M 101,000 shares | -100% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.